Holloman Energy Corp
Hero Technologies Inc. operates as an early-stage cannabis company. It focuses on the provision of BlackBox, an aeroponic cannabis cultivation system that provides optimal growing conditions to enhance photosynthesis and the cultivation of large flowering plants and create increased harvest efficiencies. The company also intends to offer cannabis genetic engineering farmland for medical and recre… Read more
Holloman Energy Corp (HENC) - Net Assets
Latest net assets as of September 2023: $43.83K USD
Based on the latest financial reports, Holloman Energy Corp (HENC) has net assets worth $43.83K USD as of September 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($143.61K) and total liabilities ($99.77K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $43.83K |
| % of Total Assets | 30.52% |
| Annual Growth Rate | N/A |
| 5-Year Change | -101.78% |
| 10-Year Change | -101.72% |
| Growth Volatility | 34.47 |
Holloman Energy Corp - Net Assets Trend (2005–2022)
This chart illustrates how Holloman Energy Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Holloman Energy Corp (2005–2022)
The table below shows the annual net assets of Holloman Energy Corp from 2005 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-12-31 | $-190.32K | -1121.43% |
| 2021-12-31 | $-15.58K | +99.10% |
| 2020-12-31 | $-1.72 Million | +18.53% |
| 2019-12-31 | $-2.11 Million | -119.79% |
| 2018-12-31 | $10.68 Million | +1.33% |
| 2017-12-31 | $10.54 Million | +1.45% |
| 2016-12-31 | $10.39 Million | -0.16% |
| 2015-12-31 | $10.41 Million | -11.41% |
| 2014-12-31 | $11.74 Million | +6.30% |
| 2013-12-31 | $11.05 Million | -4.13% |
| 2012-12-31 | $11.52 Million | -1.06% |
| 2011-12-31 | $11.65 Million | -0.51% |
| 2010-12-31 | $11.71 Million | -10.62% |
| 2009-12-31 | $13.10 Million | -28.80% |
| 2008-12-31 | $18.40 Million | +22.72% |
| 2007-12-31 | $14.99 Million | +133240.50% |
| 2006-12-31 | $-11.26K | -446.39% |
| 2005-12-31 | $-2.06K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Holloman Energy Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3937653200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2022)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $451.69K | % |
| Other Comprehensive Income | $27.97K | % |
| Other Components | $38.85 Million | % |
| Total Equity | $-70.75K | 100.00% |
Holloman Energy Corp Competitors by Market Cap
The table below lists competitors of Holloman Energy Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
GZ BYS PHARMACE -H-
BE:GU5
|
$20.36K |
|
AEW UK REIT Plc
LSE:AEWU
|
$20.37K |
|
KWESST Micro Systems Inc. Warrant
NASDAQ:KWESW
|
$20.42K |
|
Mirae Asset Vision Special Purpose Acquisition 3 Co.
KO:448830
|
$20.42K |
|
Roxmore Resources Inc.
TO:RM
|
$20.35K |
|
Hanwha Life Insurance Co. Ltd.
KQ:088350
|
$20.32K |
|
FIRSTGROUP
BE:FGR
|
$20.31K |
|
AGILYX AS NK -01
BE:5NQ
|
$20.29K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Holloman Energy Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from 77,746 to -70,749, a change of -148,495 (-191.0%).
- Net loss of 541,583 reduced equity.
- New share issuances of 120,000 increased equity.
- Other factors increased equity by 273,088.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-541.58K | -765.5% |
| Share Issuances | $120.00K | +169.61% |
| Other Changes | $273.09K | +386.0% |
| Total Change | $- | -191.00% |
Book Value vs Market Value Analysis
This analysis compares Holloman Energy Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-12-31 | $0.00 | $0.00 | x |
| 2006-12-31 | $0.00 | $0.00 | x |
| 2007-12-31 | $0.24 | $0.00 | x |
| 2008-12-31 | $0.21 | $0.00 | x |
| 2009-12-31 | $0.13 | $0.00 | x |
| 2010-12-31 | $0.11 | $0.00 | x |
| 2011-12-31 | $0.11 | $0.00 | x |
| 2012-12-31 | $0.10 | $0.00 | x |
| 2013-12-31 | $0.10 | $0.00 | x |
| 2014-12-31 | $0.11 | $0.00 | x |
| 2015-12-31 | $0.09 | $0.00 | x |
| 2016-12-31 | $0.09 | $0.00 | x |
| 2017-12-31 | $0.08 | $0.00 | x |
| 2018-12-31 | $0.08 | $0.00 | x |
| 2019-12-31 | $-0.01 | $0.00 | x |
| 2020-12-31 | $-0.01 | $0.00 | x |
| 2021-12-31 | $0.00 | $0.00 | x |
| 2022-12-31 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Holloman Energy Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: -0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-251.25%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | 0.00% | 0.00% | 0.00x | 0.00x | $-19.87K |
| 2006 | 0.00% | 0.00% | 0.00x | 0.00x | $-27.07K |
| 2007 | -10.06% | -2557.80% | 0.00x | 1.59x | $-3.01 Million |
| 2008 | 4.39% | 0.00% | 0.00x | 1.39x | $-1.03 Million |
| 2009 | -66.03% | 0.00% | 0.00x | 1.34x | $-9.96 Million |
| 2010 | -21.07% | 0.00% | 0.00x | 1.43x | $-3.64 Million |
| 2011 | -4.49% | -1304.43% | 0.00x | 1.43x | $-1.69 Million |
| 2012 | -5.24% | -121.83% | 0.03x | 1.53x | $-1.76 Million |
| 2013 | -4.91% | 0.00% | 0.00x | 1.56x | $-1.65 Million |
| 2014 | 2.76% | 0.00% | 0.00x | 1.39x | $-850.65K |
| 2015 | -16.54% | 0.00% | 0.00x | 1.57x | $-2.76 Million |
| 2016 | -0.87% | 0.00% | 0.00x | 1.60x | $-1.13 Million |
| 2017 | -1.25% | 0.00% | 0.00x | 1.58x | $-1.19 Million |
| 2018 | -0.32% | 0.00% | 0.00x | 1.56x | $-1.10 Million |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-12.67 Million |
| 2020 | 0.00% | -3054224.87% | 0.00x | 0.00x | $-5.84 Million |
| 2021 | -4398.94% | -224262.30% | 0.01x | 2.40x | $-3.43 Million |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $-534.51K |
Industry Comparison
This section compares Holloman Energy Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Holloman Energy Corp (HENC) | $43.83K | 0.00% | 2.28x | $20.36K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |